Language selection

Search

Details for: ACH-ESCITALOPRAM

Company: ACCORD HEALTHCARE INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02434652ACH-ESCITALOPRAMESCITALOPRAM (ESCITALOPRAM OXALATE)10 MGTABLETORAL
02434660ACH-ESCITALOPRAMESCITALOPRAM (ESCITALOPRAM OXALATE)20 MGTABLETORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) - Assessing the Potential Risk of Autism
Summary Safety Review - Antidepressants - Assessing the Potential Risk of Serious Eye Disorder (Angle-Closure Glaucoma)
Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-norepinephrine Reuptake Inhibitors (SNRIs) - Assessing the Potential Risk of Sexual Dysfunction despite Treatment Discontinuation

Consumer Information

This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.

What the medication is used for

ACH-Escitalopramhas been prescribed to you by your doctor to relieve your symptoms of depression, anxiety, or obsessivecompulsive disorder.Treatment with these types of medications is most safe and effective when you and your doctor have good communication about how you are feeling.

What it does

ACH-Escitalopram belongs to a group of medicines known as antidepressants, more specifically to the family of medicines called SSRIs (Selective Serotonin Reuptake Inhibitors).

ACH-Escitalopramis thought to work by increasing the levels of a chemical in the brain called serotonin (5- hydroxytryptamine). Disturbances in the serotoninsystem are considered an important factor in the development of depression and related diseases.

When it should not be used

When it shouldnot be used:

  • Do not use ACH-Escitalopram at the same time as pimozide.
  • Do not use ACH-Escitalopram if you are currently or have recently taken monoamine oxidase antidepressants (e.g. phenelzine sulphate, moclobemide).
  • Do not take ACH-Escitalopramif you are allergic to it, or to any ofthe components ofits formulation (for list of components see the section on “What ACH-Escitalopramcontains”).
  • Stop taking ACH-Escitalopram and contact your doctor immediately if you experience an allergic reaction or any severe side effect.
  • Do not use ACH-Escitalopram if you have been diagnosed with a congenitallongQT syndrome
What the medicinal ingredient is

Escitalopram oxalate

What the non-medicinal ingredients are

ACH-Escitalopram (Escitalopram Tablets USP): Colloidal Anhydrous Silica, Croscarmellose Sodium, Hypromellose E5, Hypromellose E15, Magnesium Stearate, Microcrys talline cellulose (Avicel PH 101), Polyethylene Glycol 400, Purified Talc & Titanium dioxide (E171)

What dosage form it comes in

ACH-Escitalopram 10 mg: Each film-coated, White to off-white, oval, biconvex, film coated tablets debossed with ‘1’ and ‘0’ on either side of break line and plain on other side contains: es citalopram 10 mg (as escitalopram oxalate) in blister packs or bottles.

ACH-Escitalopram 20 mg: Eachfilm-coated, White to off-white, oval, biconvex, film coated tablets debossed with ‘2’ and ‘0’ on either side of break line and plain on other side contains: es citalopram20 mg (as escitalopram oxalate) in blister packs or bottles.

Warnings and precautions

Treatment with these types of medications is mostsafe and effective when you and your doctor have good communication about how you are feeling.

ACH-Escitalopram is not for use in children under 18 years of age.

New or WorsenedEmotional or Behavioural Problems

Particularly in the first few weeks or when doses are adjusted, a small number of patients taking drugs of this type may feel worse insteadof better, theymay experience neworworsened feelings of agitation, hostility, anxiety, or thoughts about suicide, or harm to others. Suicidal thoughts and actions can occur in any age group but may be more likely in patients 18 to 24 years old. Should this happen to you, or to those in your care, consult your doctor immediately. Close observation by a doctor is necessary in this situation. Do not discontinue your medicationon your own.

You may be more likely to think like this if you have previously hadthoughts about harmingyourself.

You may find it helpful to tell a relative or close friend that you are depressed or have an anxiety disorder, and ask themto read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behaviour.

Effects on Pregnancy and Newborns

If you are already taking / using ACH-Escitalopram and have just found out that you are pregnant, you shouldtalk to your doctor immediately. You shouldalso talk to your doctor if you are planning to become pregnant.

Possible complications at birth (from taking any newer antidepressant, including ACH-Escitalopram)

Post-marketing reports indicate that some newborns whose mothers took an SSRI (Selective Serotonin Reuptake Inhibitor) such as ACH-Escitalopram or other newer antidepressant during pregnancy have developed complications at birth requiring prolonged hospitalisation, breathing support and tube feeding. Reported symptoms include: feeding and / or breathing difficulties, bluish skin, seizures, body temperature changes, vomiting, low blood sugar, tense or overly relaxed muscles, vivid reflexes, tremor,jitteriness, irritability, lethargy,sleepiness, sleeping difficulties and constant crying. In most cases, the newer antidepressant was taken during the third trimester of pregnancy. These symptoms are consistent with either a direct adverse effect of the antidepressant on the baby, or possibly a discontinuation syndrome caused by sudden withdrawal from the drug. These symptoms normally resolve over time. However,if your baby experiences any of thesesymptoms, contact your doctor as soon as youcan.

Persistent Pulmonary Hypertension (PPHN) and newer antidepressants

When taken during pregnancy, particularly in the last 3 months of pregnancy,medicines like ACH-Escitalopram may increase the risk of a serious lung condition in babies, called persistent pulmonary hypertension of the newborn (PPHN), that causes breathing difficulties in newborns soon after birth,making the baby breathe faster and appear bluish. These symptoms usually begin during the first 24 hours after the baby is born.If this happens to your baby youshould contact your doctor immediately.

If you are pregnant and taking an SSRI, or other newer antidepressant, you should discuss the risks and benefits of the various treatment options with your doctor. It is very important that you do NOT stop taking these medications without first consulting your doctor.

Risk of Bone Fractures

Taking ACH-Escitalopram may increase your risk of breaking a bone if you are elderly or have osteoporosis or have other major risk factors for breaking a bone. You should take extra care to avoid falls especially if you get dizzy or have low blood pressure.

Angle-closure Glaucoma

ACH-Escitalopram can cause dilation of the pupil which may trigger an acute glaucoma attack in an individual with narrow ocular angles. Having your eyes examined before you take ACH-Escitalopram could help identify if you are at risk of having angle-closure glaucoma, Seek immediate medical attention if you experience:

  • eye pain
  • changes in vision
  • swelling or redness in or around the eye.

Before you use ACH-Escitalopram, tell your doctor

  • All your medical conditions,including heart problems, history of seizures, manic-depressive illness, liver or kidney disease, or diabetes
  • You have a bleeding disorder or have been told that you have low platelets
  • If you have QT / QTc prolongation or a family history of QT / QTc prolongation
  • If you have a personal history of fainting spells
  • If you have a family history of sudden cardiac death at < 50 years
  • If you have electrolyte disturbances (e.g., low blood potassium, magnesium, or calcium levels) or conditions that could lead to electrolyte disturbances (e.g., vomiting, diarrhea, dehydration)
  • If you have an eatingdisorder or are following a strict diet
  • If you had a recent bone fracture or were told you have osteoporosis orriskfactorsfor osteoporosis
  • If you are pregnant or thinking about becoming pregnant, orif you are breast feeding
  • If you are receivingelectroconvulsivetreatment
  • Any medications (prescription or non-prescription) which you are taking or have taken within the last 14 days, especially monoamine oxidase inhibitors, pimozide, any other antidepressants, triptans used to treat migraines, lithium, tramadol or drugs containing tryptophan.
  • If you ever had an allergic reaction to any medication or any ofthe ingredientsmentionedin thisleaflet.
  • Your habits of alcohol and / or street drug consumption.
  • Any natural or herbal products you are taking (e.g. St. John’s Wort)
  • If you drive a vehicle or perform hazardous tasks during your work.
Interactions with this medication

Serious Drug Interactions

Do not use ACH-Escitalopram if you are taking or have recentlytaken:

  • Monoamine oxidase inhibitor (e.g.,phenelzine, tranylcypromine,moclobemide orselegiline)
  • Pimozide
  • Linezolid (an antibiotic)
  • Methylene blue (intravenous)

The following list includes some, butnot all, ofthe drugs that may increase the risk of side-effects while receiving ACH-Escitalopram. You should check with your doctor or pharmacistbefore taking any othermedication (prescription, non- prescription or natural/herbal) with ACH-Escitalopram. Other drugs that may interact with ACH-Escitalopraminclude:

  • drugs to treat heart rhythm disturbances (antiarrhythmics)
  • antipsychotics
  • opioid painkillers
  • drugs totreat infections
  • Diuretics (water pills)
  • Laxatives (including enemas)
  • Other SSRIs (citalopram) or any other antidepressant (e.g., imipramine, desipramine)
  • Lithium
  • Tryptophan
  • Cimetidine
  • Triptans (e.g., sumatriptan, zolmitriptan, naratriptan)
  • Fluconazole
  • Ketoconazole
  • Itraconazole
  • Racemic Citalopram (Celexa)
  • Warfarin
  • Omeprazole
  • Any herbal product such as St. John’s Wort
  • Certain medicines which may affect blood clotting and increase bleeding, such as oral anticoagulants (e.g., warfarin, dabigatran), acetylsalicylic acid (e.g., Aspirin) and other non- steroidal anti-inflammatory drugs (e.g.., ibuprofen)
  • Certain medicines used to treat pain, such as fentanyl (used in anaesthesia or to treat chronic pain), tramadol, tapentadol, meperidine, methadone, pentazocine.
  • Certain medicines used to treat cough, such as dextromethorphan.

Avoid drinking alcohol while taking ACH-Escitalopram

Drugs from the class that ACH-Escitalopram belongs to may increase the chance of a bleeding event such as nose bleeds, bruising and even life threatening bleeding. This is more likely if you have a history of a bleeding disorder or are taking other drugs that are known to affect your platelets.

Treatment with an SSRI in patients with diabetes may alter glycaemic control (hypoglycaemia and hyperglycaemia).

Tell your doctor all the medicines (prescription or over the counter) and natural health products that you are using or thinking of taking.

Proper use of this medication

Usual Dose

  • It is important that you take ACH-Escitalopram exactly as your doctor has instructed.
  • Usually your doctor will prescribe 10 mg per day, which you will take once daily preferably at the same time each day. If you are elderly, your doctor may prescribe a lower dose. This dose may be increased. Never change the dose of ACH-Escitalopram you are taking, or that someone in your care is taking unless your doctor tells you to.
  • You should continue to take ACH-Escitalopram even if you do not feel better, as it may take several weeks for your medication to work. Improvement may be gradual.
  • Continue to take ACH-Escitalopram for as long as your doctor recommends it. Do not stop taking your tablets abruptly even if you begin to feel better, unless you are told to do so by your doctor. Your doctor may tell you to continue to take ACH-Escitalopram for several months. Continue to follow your doctor’s instructions.

Proper Handling Instructions

  • Take everyday, as a single daily dose.
  • Swallow the tablets whole with a drink of water. Do not chew them. ACH-Escitalopram can be taken with or without food.

Overdose

If you have accidentally taken too much ACH-Escitalopram contact your doctor, the Regional Poison Control Centre or nearest hospital emergencydepartment immediately, even if you do not feel sick. If you go to the doctor or the hospital, take the ACH-Escitalopram container with you. Some of the signs of an overdose could be dizziness, tremor, agitation, convulsion, coma, nausea, vomiting, changein heart rhythm, decreased blood pressure and seizure.

If you think you, or a person you are caring for, have taken too much ACH-Escitalopram, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

Missed Dose

If you forget a dose, take the next dose as planned. Do not take a double dose to make up for a forgotten dose.

Side effects and what to do about them
  • ACH-Escitalopram may cause unwanted effects (sideeffects). These may include nausea, increased sweating, diarrhoea, fatigue, fever, constipation, clogged or runny nose, sleep disturbance, loss of appetite, increased appetite, increased weight, decreased interest in sex, decreased ability to reach orgasm, erectile dysfunction, anxiety, restlessness, abnormal dreams, difficulties falling asleep, drowsiness, yawning, tremor (shakiness), prickling of the skin, dizziness, dry mouth, heartburn, pain in muscles and joints, stomach pain and changes in heart rate.
  • Contact your doctor before stopping or reducing your dosage of ACH-Escitalopram. Symptoms such as dizziness, abnormal dreams, electric shock sensations, agitation, anxiety, emotional indifference, difficulty concentrating, headache, migraine, tremor (shakiness), nausea, vomiting, sweating or other symptoms may occur after stopping or reducing the dosage of escitalopram. Such symptoms may also occur if a dose is missed. These symptoms usually disappear without needing treatment. Tell your doctor immediately if you have these or any other symptoms. Your doctor may adjust the dosage of escitalopram to reduce the symptoms.
  • Side-effects are often mild and may disappear after a few days. If they are troublesome or persistent, or if you develop any other unusual side-effects while taking ACH-Escitalopram, please consult your doctor.
  • Usually ACH-Escitalopram does not affect your ability to carry out normal daily activities. However, you should not drive a car or operate machinery until you are reasonably certain that ACH-Escitalopram does not affect you adversely.
SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM
Symptom / effect Talk to your healthcare professional Only if severe Talk to your healthcare professional In all cases Stop taking drug and get immediate medical help
Uncommon
Allergic reactions:
red skin, hives, itching, swelling of the lips, face, tongue, throat, trouble breathing, wheezing, shortness of breath, skin rashes, blisters of the skin, sores or pain in the mouth or eyes
   
Allergic reactions:
skin rash alone, hives alone
   
Alteration of blood sugar control in patients with diabetes: Low blood sugar (symptoms of dizziness, lack of energy, drowsiness, headache, trembling, sweating) or High blood sugar (symptoms of increased thirst, increased urination, weakness, confusion, fruity breath odour)    
Low Platelets:
Bruising or unusual bleeding from the skin or other areas
   
Hallucinations:
Strange visions or sounds
   
Mania: Overactive behaviour and thoughts    
Uncontrollable movements of the body or face    
Inability tourinate    
Rare
Serotonin syndrome: a combination of symptoms, possibly including: agitation, confusion, tremor, sudden jerking of muscles, high fever    
Low sodium level in blood:
Symptoms of tiredness, weakness, confusion combined with achy, stiff or uncoordinated muscles
   
Glaucoma: Eye pain, change in vision, swelling or redness in or around the eye    
Very Rare
Seizures: Loss of consciousness with uncontrollable shaking (“fit”)    
Liver disorder: symptoms include nausea, vomiting, loss of appetite combined with itching, yellowing of the skin or eyes, dark urine    
Gastrointestinal bleeding: Vomiting blood or passing blood in stools    
See Warnings & Precautions
New or Worsened Emotional or Behavioural Problems    
Akathisia: Feeling restless and unable to sit or stand still    
Unknown
Abnormal heart rate or rhythm, palpitations, fainting    

This list is not a complete list of side effects. If you have any unexpected effects while taking this drug, contact your doctor or pharmacist.

How to store
  • As with all medicines, keep ACH-Escitalopram out of the reach and sight of children.
  • Store your ACH-Escitalopram (Escitalopram tablets USP) at room temperature (15-30°C) in a dry place and keep the container tightly closed.
  • There is an expiry date on the label. Do not use the medicine after this date.
  • If your doctor tells you to stop taking your medicine you should return any leftover tablets to the pharmacist, unless the doctor tells you to keep them at home.

REMEMBER: This medicine is for YOU. Only a doctor can prescribe it, so never offer it to any other person, even if their symptoms seem to be the same as yours.

Reporting side effects

REPORTING SIDE EFFECTS

You can report any suspected side effects associated with the use of health products to Health Canada by:

NOTE: Contact your health professional if you need information about how to manage your side effects.The Canada Vigilance Program does not provide medical advice.

More information

If you want more information about ACH-ESCITALOPRAM:

This leaflet was prepared by:

Accord Healthcare Inc.
3535 boul. St. Charles suite 704
Kirkland, QC, H9H 5B9
Canada

Last Revised: June 17, 2021

Date modified: